Omnicell, Inc. (OMCL)

Market Cap	1.61B
Revenue (ttm)	1.11B
Net Income (ttm)	12.53M
Shares Out	46.76M
EPS (ttm)	0.27
PE Ratio	127.67
Forward PE	19.32
Dividend	n/a
Ex-Dividend Date	n/a

Volume	357,689
Open	34.99
Previous Close	35.14
Day's Range	34.05 - 35.09
52-Week Range	25.12 - 55.75
Beta	0.85
Analysts	Buy
Price Target	51.00 (+47.96%)
Earnings Date	May 1, 2025

About OMCL

Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital; and specialized automated dispensing systems for hospitals, health systems, and post-acute care facilities. It also provides central pharmacy disp...

• Industry: Health Information Services
• Sector: Healthcare
• IPO Date: Aug 7, 2001
• Employees: 3,670
• Stock Exchange: NASDAQ
• Ticker Symbol: OMCL
• Website: https://www.omnicell.com

Analyst Forecast

According to 6 analysts, the average rating for OMCL stock is "Buy." The 12-month stock price forecast is $51.0, which is an increase of 47.96% from the latest price.

Price Target

$51.0

(47.96% upside)

Analyst Consensus: Buy